Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors.

Zhu B, Shao Q, Cui J, Fu Z, Ma Y

Open source

DOI
10.3389/fmed.2026.1765715
Published
2026
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1765715,
  title = {Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors.},
  author = {Zhu B and Shao Q and Cui J and Fu Z and Ma Y},
  year = {2026},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2026.1765715},
  url = {https://doi.org/10.3389/fmed.2026.1765715}
}

RIS

TY  - JOUR
TI  - Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors.
AU  - Zhu B
AU  - Shao Q
AU  - Cui J
AU  - Fu Z
AU  - Ma Y
PY  - 2026
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1765715
UR  - https://doi.org/10.3389/fmed.2026.1765715
ER  - 

APA

B, Z., Q, S., J, C., Z, F., & Y, M. (2026). Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors.. Frontiers in medicine. https://doi.org/10.3389/fmed.2026.1765715

Source records